AlphaYouBH
Insider selling
Brad Hively sold $1.9M of Starling Oncology, Inc. (STLN) stock
Brad Hively, Dir of Starling Oncology, Inc. (STLN), sold 298,853 shares of STLN stock worth $1.9M, per an SEC Form 4 filed Aug 24, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 21, 2026, 3 days before it was made public.
STLN has moved +9.0% since the trade date, from $6.46 to $7.05 (Sep 22, 2026 close).
- Traded
- Aug 21, 2026
- Disclosed
- Aug 24, 2026
- Filing delay
- 3 days
- Price since
- +9.0%
- Role
- Dir
- Source
- SEC Form 4
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.